Objective To study the eye complication situation of patients initially diagnosed with Acquired Immunodeficiency Syndrome (AIDS); to analyze the main factors that cause damage to eyesight; and to provide a basis for the prevention and control of damage to vision in Shanghai. Methods This was a cross-sectional investigation. A cohort study of patients initially diagnosed with AIDS was conducted in the Shanghai public health clinic center from March 2011 to February 2012. The patients underwent a full and thorough set of ophthalmology examinations. Natural and best corrected distance vision were tested with a Snellen chart. The anterior segment and fundus were examined by slit lamp microscopy and direct ophthalmoscopy. The data were input in compliance with the WHO visual impairment standard classification, and the causes of blindness and low vision damage were analyzed. The data were collected and measured by percentage, and analyzed with a chi-square test. Results Among 358 patients initially diagnosed with AIDS, 286 patients (79%) signed an informed consent to allow the eye clinic to examine them. Of the 286 patients, 58.4% had ocular complications. The highest incidence was 36.01% for dry eyes, the second highest was 19.9% for conjunctivitis and the third was 8.39% for cytomegalovirus retinitis (CMVR). The leading cause of blindness was 40% from CMVR and the second leading causes were 30% from retinal microvascular lesions (HIVM) and glaucoma. The rate of blindness increased with a CD4+T lymphocyte level less than 250 cells/μl. Conclusion The ocular complications in patients initially diagnosed with AIDS in Shanghai are higher than in the United States and other countries. CMVR was the main reason for damage to eyesight. It is recommended to move more quickly to establish a reliable CMVR screening and treatment network to improve the quality of life of AIDS patients.
陆慧红,王志良,沈银忠,卢洪洲,范先群. 上海市艾滋病初诊患者眼部并发症及致盲原因调查分析[J]. 中华眼视光学与视觉科学杂志, 2013, 15(2): 120-124.
LU Hui-hong,WANG Zhi-liang,SHEN Yin-zhong,LU Hong-zhou,FAN Xianqun. A study of eye complications and causes of blindness and in patients initially diagnosed with AIDS in Shanghai. Chinese Journal of Optometry Ophthalmology and Visual Science, 2013, 15(2): 120-124. DOI: 10.3760/cma.j.issn.1674-845X.2013.02.014
Goldberg DE, Smithen LM, Angelilli A, et al. HIV-associated retinopathy in the HAART era. Retina,2005,25:633-49.
[4]
World Health Organization. International statistical classification of diseases and related health problems,10th Revision//Johnson GJ, Minassian DC, Weale R. The epidemiology of eye disease. London: Chapman & Hall Medical,1998:8-30.
[5]
Yust I, Fox Z, Burke M, et al. Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study,1994-2001. Eur J Clin Microbiol Infect Dis,2004,23:550-559.
[6]
Gharai S, Venkatesh P, Garg S, et al. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol,2008,15:264-271.
[7]
Pathanapitoon K, Ausayakhun S, Kunavisarut P, et al. Blindness and low vision in a tertiary ophthalmologic center in Thailand: the importance of cytomegalovirus retinitis. Retina,2007,27:635-640.
[8]
康来仪,潘孝彰,主编. 艾滋病防治学. 上海:复旦大学出版社,2008:65-69.
[9]
Geng S, Ye JJ, Liu LQ, et al. Diagnosis and treatment of eye disease associated with HIV infection and AIDS. Zhonghua Yan Ke Za Zhi,2009,5:1093-1098.
[10]
Jabs DA, Van Natta ML, Holbrook JT, et al. Longitudinal Study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology,2007,114:787-793.
[11]
Shi Y, Lu HZ, He TW, et al. Prevalence and clinical management of cytomegalovirus retinitis in AIDS patients in shanghai, China. BMC Infect Dis,2011,11:326-336.
[12]
Li HY, Ye JJ. Progress in the studies on cytomegalovirus retinitis. Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2003,25:223-227.
[13]
Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States,1988-1994. Clin Infect Dis,2006,43:1143-1151.
Kaleem MA, Ramsahai S, Del Fierro K, et al. Ocular findings in human immunodeficiency virus patients in Washington, DC.Int Ophthalmol,2012,32:145-151.
[17]
Gharai S, Venkatesh P, Garg S, et al. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol,2008,15:264-271.
[18]
Emina MO, Odjimogho SE. Ocular problems in HIV and AIDS patients in Nigeria. Optom Vis Sci,2010,87:979-984.
[19]
Owoeye JF, Ademola-Popoola DS. Herpes zoster infection and HIV seropositivity among eye patients-University of II orin Teaching Hospital experience. West Afr J Med,2003,22:136-138.
[20]
Suresh S, Nor-Masniwati S, Nor-Idahriani MN, et al. Serological IgG avidity test for ocular toxoplasmosis. Clin Ophthalmol,2012,6:147-150.
[21]
Ali R, Kim JY, Henderson BA. Adnexal and anterior segment manifestations of HIV/AIDS. Int Ophthalmol Clin,2007,47:15-32.